Skip to main navigation

Skip to Content

Overview
News & Events
- News Releases
- Events & Presentations
Governance
Stock Information
Financials
- SEC Filings
Resources

News Releases

Year

Sep 30, 2021

Tango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021

Aug 10, 2021

Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies

Aug 03, 2021

Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference

Apr 14, 2021

Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies

Mar 24, 2021

Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors

Print

RSS Feeds

Email Alerts

Contact IR

Tango Therapeutics, Inc
100 Binney Street, Suite 700
Cambridge, MA 02142
Tel: +1-857-320-4900

contact | careers |